Autres langues 10x Genomics, Inc.

Actions

TXG

US88025U1097

Temps réel estimé Cboe BZX Autres places de cotation 21:24:56 26/04/2024			Varia. 5j.	Varia. 1 janv.
27,51 ^USD	+2,27 %		-1,45 %	-50,80 %

18/04	10X GENOMICS, INC. : Deutsche Bank Securities maintient sa recommandation à l'achat	ZM
26/03	10x Genomics, Inc. lance commercialement l'essai d'expression génétique spatiale Visium HD	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Petition Denied For Lacking Section 112(f) Construction And Fintiv	18/04
The UPC Court Of Appeal's First Decision: What Does It Mean For The Assessment Of Inventive Step At The UPC?	17/04
UPC Court Of Appeal Overturns Preliminary Injunction In Its First Substantive Decision	15/04
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024	10/04
UPC Court Of Appeal Reverses Preliminary Injunction In First Substantive Decision	29/03
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay	26/03
10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay	26/03
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel	21/03
10X Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel	21/03
Vizgen Announces Denial of 10x Genomics Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted against 10x's Xenium Platform	14/03
10x Genomics Launches Two New Products With Single Cell Technology	13/03
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products	13/03
10x Genomics, Inc. Begins Commercial Shipments of Chromium GEM-X Products	13/03
Element Biosciences Announces Senior Vice President of Global Sales and Support	13/03
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference	20/02
10x Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
10x Genomics Q4 Net Loss Widens, Revenue Increases; Issues Outlook	15/02
Earnings Flash (TXG) 10X GENOMICS Reports Q4 Revenue $184M, vs. Street Est of $183.7M	15/02
10x Genomics: Q4 Earnings Snapshot	15/02
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024	15/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues 10x Genomics, Inc.

Actions

TXG

US88025U1097

Autres langues

Filtres